Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:22:13.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding a clinical study on HER2-positive breast cancer, including detailed descriptions of the study's purpose, methodology, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    35%
    Check dated 2025-04-16T20:33:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T14:11:44.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:15:36.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:07:32.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T16:42:53.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.